DELTA DIALOG
DELTA DIALOG is a series of discussions and interviews on AI and technology as in its development, usage in different sectors and industries, and how it engages or better said changes the world. Together with experts from diverse industries, the show explores many perspectives regarding AI and technology that has everyday implications around the world.
RECENT EPISODES
Apr 19, 2023
Content Partner
A defence of human uniqueness against AI encroachment, with Kenn Cukier
A defence of human uniqueness against AI encroachment, with Kenn Cukier Despite the impressive recent progress in AI capabilities, there are reasons why AI may be incapable of possessing a full "general intelligence". And although AI will continue to transform the workplace, some important jobs will remain outside the reach of AI. In other words, the Economic Singularity may not happen, and AGI may be impossible. These are views defended by our guest in this episode, Kenneth Cukier, the Deputy Executive Editor of The Economist newspaper.
A defence of human uniqueness against AI encroachment, with Kenn Cukier
A defence of human uniqueness against AI encroachment, with Kenn Cukier Despite the impressive recent progress in AI capabilities, there are reasons why AI may be incapable of possessing a full "general intelligence". And although AI will continue to transform the workplace, some important jobs will remain outside the reach of AI. In other words, the Economic Singularity may not happen, and AGI may be impossible. These are views defended by our guest in this episode, Kenneth Cukier, the Deputy Executive Editor of The Economist newspaper.
Apr 13, 2023
Unlocking the power of data: Breeding next-generation data scientists
Data science unlocks data’s value to enable decision-making that transforms healthcare, finance, agriculture, and transport. Its models confer competitiveness and drive vast demand for data scientists. Burgeoning data fuel the need for data science as a huge development catalyst.
Further Reading:
- Open health data will help fix India's healthcare
- Data ownership and open health: A revolution in healthcare?
- US AI Policy Targets Healthcare, Education, Climate Change
Unlocking the power of data: Breeding next-generation data scientists
Data science unlocks data’s value to enable decision-making that transforms healthcare, finance, agriculture, and transport. Its models confer competitiveness and drive vast demand for data scientists. Burgeoning data fuel the need for data science as a huge development catalyst.
Further Reading:
- Open health data will help fix India's healthcare
- Data ownership and open health: A revolution in healthcare?
- US AI Policy Targets Healthcare, Education, Climate Change
Apr 06, 2023
Open Medical Data - OMD in the US: “Nonexistent with a caveat.”
In this episode Gil Press, David Wood and Emir M. Isler explore the underdevelopment of open medical data in the United States, and the challenges faced by patients who are seeking greater access to their own medical information.
Further Reading:
- Healing US Healthcare With AI
- US must pave way for open medical data
- Can AI Fix US Healthcare?
Open Medical Data - OMD in the US: “Nonexistent with a caveat.”
In this episode Gil Press, David Wood and Emir M. Isler explore the underdevelopment of open medical data in the United States, and the challenges faced by patients who are seeking greater access to their own medical information.
Further Reading:
- Healing US Healthcare With AI
- US must pave way for open medical data
- Can AI Fix US Healthcare?
Mar 31, 2023
Delta Dialog Content Partner Series - AI, Chips and Drug Discovery
As the field of artificial intelligence continues to rapidly advance, there is growing interest in its potential applications to drug development. With the ability to process vast amounts of data and make complex predictions, AI has the potential to greatly accelerate the drug discovery process, leading to more efficient and effective treatments for a range of diseases. However, there are also important ethical and regulatory considerations that must be taken into account when using AI in drug development.
Further Reading:
- DL boosts India’s drug development - part 1
- AI Takes Shortcuts in Drug Discovery
- AI, Robotics Team in Drug Discovery
Delta Dialog Content Partner Series - AI, Chips and Drug Discovery
As the field of artificial intelligence continues to rapidly advance, there is growing interest in its potential applications to drug development. With the ability to process vast amounts of data and make complex predictions, AI has the potential to greatly accelerate the drug discovery process, leading to more efficient and effective treatments for a range of diseases. However, there are also important ethical and regulatory considerations that must be taken into account when using AI in drug development.
Further Reading:
- DL boosts India’s drug development - part 1
- AI Takes Shortcuts in Drug Discovery
- AI, Robotics Team in Drug Discovery
Mar 23, 2023
Open Medical Data – Being left behind? Pros and Cons of Digital Health in the USA
Digital health tech is upending US healthcare delivery. From wearables that track vital signs to remote consultations with doctors, tech will improve patient outcomes, cut costs, and open access to care, but concerns abound over data privacy and worsened healthcare disparities.
Further Reading:
- What is next for digital health?
- NLP breakthroughs may advance healthcare practice
- The Yuan AI 2023: DL to loom large in future AI in healthcare
Open Medical Data – Being left behind? Pros and Cons of Digital Health in the USA
Digital health tech is upending US healthcare delivery. From wearables that track vital signs to remote consultations with doctors, tech will improve patient outcomes, cut costs, and open access to care, but concerns abound over data privacy and worsened healthcare disparities.
Further Reading:
- What is next for digital health?
- NLP breakthroughs may advance healthcare practice
- The Yuan AI 2023: DL to loom large in future AI in healthcare
Mar 09, 2023
Open Medical Data – Into the hype of 2023: ChatGPT
Open medical data and AI are key to easing future pandemics. Tracking a disease guides resource allocation and target interventions, e.g., COVID-19 data enabled severely at-risk groups to be flagged, leading to vaccines and campaigns to shield them, but averting a pandemic needs infrastructure and political will. Ethics are also a factor in shared medical data.
Further Reading:
- Is ChatGPT really a ‘code red’ for Google Search? Maybe not
- Overcoming the limitations of large language models
- Is Microsoft’s big bet on OpenAI a slam dunk or long shot?
Open Medical Data – Into the hype of 2023: ChatGPT
Open medical data and AI are key to easing future pandemics. Tracking a disease guides resource allocation and target interventions, e.g., COVID-19 data enabled severely at-risk groups to be flagged, leading to vaccines and campaigns to shield them, but averting a pandemic needs infrastructure and political will. Ethics are also a factor in shared medical data.
Further Reading:
- Is ChatGPT really a ‘code red’ for Google Search? Maybe not
- Overcoming the limitations of large language models
- Is Microsoft’s big bet on OpenAI a slam dunk or long shot?
Feb 24, 2023
Open Medical Data – AI: A money making machine?
AI in healthcare improves patient outcomes, optimizes delivery, and cuts costs. In 2023, AI is set to greatly impact open medical data - a key resource for researchers and healthcare professionals to devise better treatments in tandem with AI data analysis and interpretation.
Further Reading:
- Crafting New Business Models for a New Future
- The next trillion-dollar business: personal AI assistants - part 1
- The Yuan AI 2023: Transitioning from narrow AI to broad AI
Open Medical Data – AI: A money making machine?
AI in healthcare improves patient outcomes, optimizes delivery, and cuts costs. In 2023, AI is set to greatly impact open medical data - a key resource for researchers and healthcare professionals to devise better treatments in tandem with AI data analysis and interpretation.
Further Reading:
- Crafting New Business Models for a New Future
- The next trillion-dollar business: personal AI assistants - part 1
- The Yuan AI 2023: Transitioning from narrow AI to broad AI
Jan 25, 2023
Content Partner
Presenting gedanken experiments, with David Brin
Sci-fi author Davin Brin, winner of the Hugo, Locus, Campbell, and Nebula awards, whose narratives feature sci-tech change that is plausible rather than pure fantasy, talks with The Yuan about ETs, solar exploration, what the next destination is on humanity’s stellar trek, and all manner of otherworldly phenomena in this wide-ranging Delta Dialog brought to you in collaboration with our content partner London Futurists.
Presenting gedanken experiments, with David Brin
Sci-fi author Davin Brin, winner of the Hugo, Locus, Campbell, and Nebula awards, whose narratives feature sci-tech change that is plausible rather than pure fantasy, talks with The Yuan about ETs, solar exploration, what the next destination is on humanity’s stellar trek, and all manner of otherworldly phenomena in this wide-ranging Delta Dialog brought to you in collaboration with our content partner London Futurists.
Jan 18, 2023
Content Partner
Inventing the future of computing, with Alessandro Curioni
Alessandro Curioni, Director of IBM Research, chats with The Yuan about next-level AI - exemplified by ChatGPT, MidJourney and Stable Diffusion - and its awesome future implications. He also draws on his 25-year experience with the tech titan to explain how we got here, and where we’re going in this episode of Delta Dialog, in cooperation with our content partner London Futurists.
Inventing the future of computing, with Alessandro Curioni
Alessandro Curioni, Director of IBM Research, chats with The Yuan about next-level AI - exemplified by ChatGPT, MidJourney and Stable Diffusion - and its awesome future implications. He also draws on his 25-year experience with the tech titan to explain how we got here, and where we’re going in this episode of Delta Dialog, in cooperation with our content partner London Futurists.
Jan 11, 2023
Content Partner
Assessing quantum computing, with Ignacio Cirac
Quantum computing is an enigma. Unlike classical computing, which uses binary digits - bits - that are either on or off, quantum computing uses qubits, which are simultaneously both on and off. Prof Ignacio Cirac, Director of the Max Planck Institute of Quantum Optics, discusses how this massively boosts its computational might in this installment of The Yuan’s Delta Dialog, in collaboration with our content partner London Futurists.
Assessing quantum computing, with Ignacio Cirac
Quantum computing is an enigma. Unlike classical computing, which uses binary digits - bits - that are either on or off, quantum computing uses qubits, which are simultaneously both on and off. Prof Ignacio Cirac, Director of the Max Planck Institute of Quantum Optics, discusses how this massively boosts its computational might in this installment of The Yuan’s Delta Dialog, in collaboration with our content partner London Futurists.
CAST
Host and editor
Emir Mustafa Isler
Emir Mustafa Isler
Commentator
David Wood
David Wood
Social media editor
Yixin Sui
Yixin Sui
Art director
Xiaoyan Xu
Xiaoyan Xu
Schedule planner
Kim Taylor
Kim Taylor
Technical support
Yibiao Peng
Yibiao Peng
Producer
Shifeng Wang
Shifeng Wang
Media support
